Unraveling a history of overlap: A phenotypic comparison of RBCK1-related disease and glycogen storage disease type IV

被引:0
作者
Crane, Haley M. [1 ]
Asher, Stephanie [2 ]
Conway, Laura [1 ]
Drivas, Theodore G. [2 ]
Kallish, Staci [2 ]
机构
[1] Univ Penn, Master Sci Genet Counseling Program, Philadelphia, PA USA
[2] Penn Med, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA
关键词
glycogen storage disease type IV; GSD IV; phenotypic comparison; rare disease research; RBCK1-related disease; retrospective chart review; POLYGLUCOSAN BODY MYOPATHY; BRANCHING ENZYME DEFICIENCY; SEVERE CONGENITAL HYPOTONIA; SKELETAL-MUSCLE; NULL MUTATIONS; NEONATAL FORM; DIAGNOSIS; BODIES; HEART;
D O I
10.1002/ajmg.a.63574
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
RBCK1-related disease is a rare, multisystemic disorder for which our current understanding of the natural history is limited. A number of individuals initially carried clinical diagnoses of glycogen storage disease IV (GSD IV), but were later found to harbor RBCK1 pathogenic variants, demonstrating challenges of correctly diagnosing RBCK1-related disease. This study carried out a phenotypic comparison between RBCK1-related disease and GSD IV to identify features that clinically differentiate these diagnoses. Literature review and retrospective chart review identified 25 individuals with RBCK1-related disease and 36 with the neuromuscular subtype of GSD IV. Clinical features were evaluated to assess for statistically significant differences between the conditions. At a system level, any cardiac, autoinflammation, immunodeficiency, growth, or dermatologic involvement were suggestive of RBCK1, whereas any respiratory involvement suggested GSD IV. Several features warrant further exploration as predictors of RBCK1, such as generalized weakness, heart transplant, and recurrent infections, among others. Distinguishing RBCK1-related disease will facilitate correct diagnoses and pave the way for accurately identifying affected individuals, as well as for developing management recommendations, treatment, and an enhanced understanding of the natural history. This knowledge may also inform which individuals thought to have GSD IV should undergo reevaluation for RBCK1.
引用
收藏
页数:13
相关论文
共 38 条
[1]   Prenatal diagnosis of glycogen storage disease type IV [J].
Akman, H. Orhan ;
Karadimas, Charalampos ;
Gyftodimou, Yolanda ;
Grigoriadou, Maria ;
Kokotas, Haris ;
Konstantinidou, Anastasia ;
Anninos, Hector ;
Patsouris, Efstratios ;
Thaker, Harshwardhan M. ;
Kaplan, Jeffrey B. ;
Besharat, Isaam ;
Hatzikonstantinou, Konstantina ;
Fotopoulos, Spyridon ;
DiMauro, Salvatore ;
Petersen, Michael B. .
PRENATAL DIAGNOSIS, 2006, 26 (10) :951-955
[2]   Null mutations and lethal congenital form of glycogen storage disease type IV [J].
Assereto, Stefania ;
van Diggelen, Otto P. ;
Diogo, Luisa ;
Morava, Eva ;
Cassandrini, Denise ;
Carreira, Isabel ;
de Boode, Willem-Pieter ;
Dilling, Jildau ;
Garcia, Paula ;
Henriques, Margarida ;
Rebelo, Olinda ;
ter Laak, Henk ;
Minetti, Carlo ;
Bruno, Claudio .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (02) :445-450
[3]   Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene [J].
Bao, Y ;
Kishnani, P ;
Wu, JY ;
Chen, YT .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :941-948
[4]   Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency [J].
Boisson, Bertrand ;
Laplantine, Emmanuel ;
Prando, Carolina ;
Giliani, Silvia ;
Israelsson, Elisabeth ;
Xu, Zhaohui ;
Abhyankar, Avinash ;
Israel, Laura ;
Trevejo-Nunez, Giraldina ;
Bogunovic, Dusan ;
Cepika, Alma-Martina ;
MacDuff, Donna ;
Chrabieh, Maya ;
Hubeau, Marjorie ;
Bajolle, Fanny ;
Debre, Marianne ;
Mazzolari, Evelina ;
Vairo, Donatella ;
Agou, Fabrice ;
Virgin, Herbert W. ;
Bossuyt, Xavier ;
Rambaud, Caroline ;
Facchetti, Fabio ;
Bonnet, Damien ;
Quartier, Pierre ;
Fournet, Jean-Christophe ;
Pascual, Virginia ;
Chaussabel, Damien ;
Notarangelo, Luigi D. ;
Puel, Anne ;
Israel, Alain ;
Casanova, Jean-Laurent ;
Picard, Capucine .
NATURE IMMUNOLOGY, 2012, 13 (12) :1178-+
[5]   Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV) [J].
Bruno, C ;
van Diggelen, OP ;
Cassandrini, D ;
Gimpelev, M ;
Giuffrè, B ;
Donati, MA ;
Introvini, P ;
Alegria, A ;
Assereto, S ;
Morandi, L ;
Mora, M ;
Tonoli, E ;
Mascelli, S ;
Traverso, M ;
Pasquini, E ;
Bado, M ;
Vilarinho, L ;
van Noort, G ;
Mosca, F ;
DiMauro, S ;
Zara, F ;
Minetti, C .
NEUROLOGY, 2004, 63 (06) :1053-1058
[6]   Non-lethal congenital hypotonia due to glycogen storage disease type IV [J].
Burrow, TA ;
Hopkin, RJ ;
Bove, KE ;
Miles, L ;
Wong, BL ;
Choudhary, A ;
Bali, D ;
Li, SC ;
Chen, YT .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (08) :878-882
[7]   Glycogen Storage Disease Type IV Diagnosed at Fetal Autopsy [J].
Butler, Daniel C. ;
Glen, W. Bailey, Jr. ;
Schandl, Cynthia ;
Phillips, Angelina .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2020, 23 (04) :301-305
[8]   Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China [J].
Chen, Lin ;
Wang, Nan ;
Hu, Wenbin ;
Yu, Xuen ;
Yang, Renming ;
Han, Yongzhu ;
Yan, Yan ;
Nian, Na ;
Sha, Congbo .
BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
[9]  
DELABLANCHARDIERE A, 1994, PRESSE MED, V23, P1124
[10]   Familial polyglucosan body myopathy with unusual phenotype [J].
Fanin, M. ;
Nascimbeni, A. C. ;
Savarese, M. ;
Papa, V. ;
Cenacchi, G. ;
Nigro, V. ;
Angelini, C. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (03) :385-390